Lunai Bioworks Inc.
Pharmaceutical company · Suite 906 Los Angeles, California, United States · Nasdaq: LNAI
Lunai Bioworks Inc. is a pharmaceutical company headquartered in Suite 906 Los Angeles, California, United States. Its shares trade on Nasdaq under the ticker LNAI. It has reported private securities offerings to the US SEC, most recently $107 million sold in a notice filed in 2024.
Lunai Bioworks at a glance
What does Lunai Bioworks do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $106.8 million sold (2024).
Frequently asked questions about Lunai Bioworks
Where is Lunai Bioworks headquartered?
Lunai Bioworks Inc. is headquartered in Suite 906 Los Angeles, California, United States.
What does Lunai Bioworks do?
Lunai Bioworks Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Lunai Bioworks a public company?
Yes. Lunai Bioworks Inc. trades on Nasdaq under the ticker LNAI.
Similar companies
- Niagen Bioscience, Inc.Los Angeles, California, United States
- Puma Biotechnology, Inc.Los Angeles, California, United States
- Capricor IncLos Angeles, California, United States
- Immix Biopharma, Inc.Los Angeles, California, United States
- Avenzoar Pharmaceuticals, Inc.Los Angeles, California, United States
- Targeted Medical Pharma, Inc.Los Angeles, California, United States
- Kairos Pharma, LTD.Los Angeles, California, United States
- Pelage Pharmaceuticals, Inc.Los Angeles, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences